← Back to home

AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY

Clinical trials for AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY trials appear

Sign up with your email to follow new studies for AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First human test for promising brain disease drug begins

Disease control Ongoing

This is a very early study to check the safety of a new drug called ART5803 in healthy people. The drug is being developed to treat a serious brain inflammation disease. Researchers want to see how the drug behaves in the body when given after a common treatment called IVIG.

Matched conditions: AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY

Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY

Get alerted when new AUTOIMMUNE ENCEPHALITIS CAUSED BY N-METHYL D-ASPARTATE RECEPTOR ANTIBODY trials appear

First human test for promising brain disease drug begins